106 related articles for article (PubMed ID: 8438397)
1. Cyclosporine and rapamycin block protein kinase C-mediated induction of the activation signal, activator of DNA replication, in cell-free assay.
Kimball P; Kerman RH; Williams J; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):518-9. PubMed ID: 8438397
[No Abstract] [Full Text] [Related]
2. Cyclosporine and rapamycin affect protein kinase C induction of the intracellular activation signal, activator of DNA replication.
Kimball PM; Kerman RK; Van Buren CT; Lewis RM; Katz S; Kahan BD
Transplantation; 1993 May; 55(5):1128-32. PubMed ID: 8497893
[TBL] [Abstract][Full Text] [Related]
3. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
[No Abstract] [Full Text] [Related]
4. P70 S6 kinase assay: a pharmacodynamic monitoring strategy for rapamycin; assay development.
Gallant HL; Yatscoff RW
Transplant Proc; 1996 Dec; 28(6):3058-61. PubMed ID: 8962186
[No Abstract] [Full Text] [Related]
5. Modes of action of FK506, cyclosporin A, and rapamycin.
Morris R
Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
[No Abstract] [Full Text] [Related]
6. Rapamycin suppresses in vitro immunoglobulin production by human lymphocytes.
Luo H; Chen H; Daloze P; Chang J; Wu J
Transplant Proc; 1991 Aug; 23(4):2236-8. PubMed ID: 1871858
[No Abstract] [Full Text] [Related]
7. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury.
Puglisi RN; Strande L; Santos M; Schulte G; Hewitt CW; Whalen TV
J Surg Res; 1996 Oct; 65(2):115-8. PubMed ID: 8903456
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
[No Abstract] [Full Text] [Related]
9. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
Bierer BE
Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
[No Abstract] [Full Text] [Related]
10. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
Wu J; Palladino MA; Figari IS; Morris RE
Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683
[No Abstract] [Full Text] [Related]
11. Inhibitors of protein kinase C block activation of B lymphocytes by bacterial lipopolysaccharide.
Rush JS; Waechter CJ
Biochem Biophys Res Commun; 1987 Jun; 145(3):1315-20. PubMed ID: 3496881
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pharmacology on protein kinase C].
Hidaka H; Naka M
Tanpakushitsu Kakusan Koso; 1986 May; 31(6):534-48. PubMed ID: 3529244
[No Abstract] [Full Text] [Related]
13. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
14. Adhesiveness and proliferation of epithelial cells are differentially modulated by activation and inhibition of protein kinase C in a substratum-dependent manner.
Zhou Y; Dziak E; Opas M
J Cell Physiol; 1993 Apr; 155(1):14-26. PubMed ID: 8468359
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
Powell JD; Lerner CG; Schwartz RH
J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin effects on immunologic reconstitution.
Vogelsang GB; Hess AD
Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
[No Abstract] [Full Text] [Related]
17. Mechanism of action of rapamycin (Sirolimus, Rapamune).
Molnar-Kimber KL
Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
[No Abstract] [Full Text] [Related]
18. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
19. Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture.
Seidel ER; Ragan VL
Br J Pharmacol; 1997 Feb; 120(4):571-4. PubMed ID: 9051292
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin.
Carlson RP; Sehgal SN; Lewis AJ
Clin Exp Rheumatol; 1993; 11 Suppl 8():S129. PubMed ID: 8324938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
